HomeOKUR • NASDAQ
add
Onkure Therapeutics Inc
Previous close
$17.58
Day range
$16.65 - $17.61
Year range
$9.80 - $77.60
Market cap
234.11M USD
Avg Volume
61.21K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.34M | 66.12% |
Net income | -14.14M | -72.79% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -14.23M | -66.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 18.63M | — |
Total assets | 25.47M | — |
Total liabilities | 19.22M | — |
Total equity | 6.25M | — |
Shares outstanding | 1.34M | — |
Price to book | -0.19 | — |
Return on assets | -143.43% | — |
Return on capital | -225.04% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -14.14M | -72.79% |
Cash from operations | -6.47M | 41.65% |
Cash from investing | -10.00K | 83.33% |
Cash from financing | 5.87M | 293,500.00% |
Net change in cash | -615.00K | 94.49% |
Free cash flow | -1.30M | — |
About
Founded
2011
Headquarters
Website
Employees
50
